KIAA1549-BRAF fusions have previously been shown to be associated with better patient survival [3, 15] while BRAFV600E has been linked to increased likelihood of tumour progression and transformation in low grade glioma [17, 25]. This evidence concerns the gene KIAA1549 and glioma.